Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,747 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Wide variation in tissue, systemic, and drain fluid exposure after oxaliplatin-based HIPEC: results of the GUTOX study.
de Jong LAW, Elekonawo FMK, Lambert M, de Gooyer JM, Verheul HMW, Burger DM, de Wilt JHW, Chatelut E, Ter Heine R, de Reuver PR, Bremers AJA, van Erp NP. de Jong LAW, et al. Among authors: lambert m. Cancer Chemother Pharmacol. 2020 Jul;86(1):141-150. doi: 10.1007/s00280-020-04107-y. Epub 2020 Jun 27. Cancer Chemother Pharmacol. 2020. PMID: 32594200 Free PMC article. Clinical Trial.
Correction to: Wide variation in tissue, systemic, and drain fluid exposure after oxaliplatin‑based HIPEC: results of the GUTOX study.
de Jong LAW, Elekonawo FMK, Lambert M, de Gooyer JM, Verheul HMW, Burger DM, de Wilt JHW, Chatelut E, Ter Heine R, de Reuver PR, Bremers AJA, van Erp NP. de Jong LAW, et al. Among authors: lambert m. Cancer Chemother Pharmacol. 2022 Aug;90(2):189-190. doi: 10.1007/s00280-022-04450-2. Cancer Chemother Pharmacol. 2022. PMID: 35731259 Free PMC article. No abstract available.
Population pharmacokinetic analysis reveals no impact of aprepitant on the pharmacokinetics of ifosfamide, 2-dechloroifosfamide, and 3-dechloroifosfamide.
Valentin T, Lambert M, Chaltiel L, Allal B, Mseddi M, Yakoubi M, Chevreau C, Toulmonde M, Firmin N, Filleron T, Chatelut E. Valentin T, et al. Among authors: lambert m. Eur J Pharm Sci. 2023 Jun 1;185:106420. doi: 10.1016/j.ejps.2023.106420. Epub 2023 Mar 5. Eur J Pharm Sci. 2023. PMID: 36882147 Free article.
NSAID exposure delays time-to-pregnancy in patients with spondyloarthritis: an analysis of the GR2 prospective cohort.
Hamroun S, Couderc M, Flipo RM, Sellam J, Richez C, Dernis E, Frazier A, Gossec L, Gervais E, Marotte H, Dunogeant L, Lukas C, Deroux A, Guettrot-Imbert G, Le Guern V, Costedoat-Chalumeau N, Molto A; GR2 study group. Hamroun S, et al. RMD Open. 2024 Nov 29;10(4):e004745. doi: 10.1136/rmdopen-2024-004745. RMD Open. 2024. PMID: 39615886 Free PMC article.
The Saliva and Muscle Study (SaMu): Rationale and Protocol for Associations between Salivary Microbiome and Accelerated Muscle Ageing.
Crombez L, Descamps A, Hirmz H, Lambert M, Calewaert J, Siluk D, Markuszewski M, Biesemans M, Petrella G, Cicero D, Cesaroni S, Stokowy T, Gerber GK, Tataru C, Naumovski P, Elewaut D, Van De Looverbosch C, Calders P, Van Den Noortgate N, De Spiegeleer B, Wynendaele E, De Spiegeleer A. Crombez L, et al. Among authors: lambert m. J Frailty Aging. 2024;13(4):331-340. doi: 10.14283/jfa.2024.75. J Frailty Aging. 2024. PMID: 39574252
2,747 results